2023-503332-40-00已完成1 期
A study in healthy people to test how well repeated doses of BI 3032950 are tolerated
Boehringer Ingelheim International GmbH, Boehringer Ingelheim International GmbH1 个研究点 分布在 1 个国家目标入组 40 人开始时间: 2023年8月1日最近更新:
试验速览
- 阶段
- 1 期
- 状态
- 已完成
- 发起方
- 入组人数
- 40
- 试验地点
- 1
研究概览
简要总结
暂无简介。
入排标准
- 年龄范围
- 18 years 至 65+ years（65+ Years, 18-64 Years）
- 性别
- Male
- 接受健康志愿者
- 是
入选标准
- 未提供
排除标准
- 未提供
研究者
CT Disclosure & Data Transparency
Scientific
Boehringer Ingelheim International GmbH
研究点 (1)
Loading locations...
相似试验
招募中
1 期
A study in healthy people to test how 3 different formulations of BI 764198 are taken up in the body and how this is influenced by food2024-519615-34-00Boehringer Ingelheim International GmbH17
招募中
1 期
A study in healthy people to compare how 2 different formulations of survodutide are taken up in the body2025-521419-37-00Boehringer Ingelheim International GmbH16
已完成
1 期
Study with healthy volunteers to investigate the safety, tolerability, blood concentration and some effects of various amounts of the pharmaceutical substance SR-8782023-507753-15-00SciRhom GmbH52
已完成
1 期
A study in healthy volunteers to find out how long aticaprant stays in and acts on the body when administered with or without food and with or without fluconazole2023-510472-31-00Janssen Cilag International18
已完成
1 期
A study in healthy people to compare two different tablets of BI 685509 and to test how food and esomeprazole influence the amount of BI 685509 in the blood2023-506367-33-00Boehringer Ingelheim International GmbH16